APA (7th ed.) Citation

AM, K., AA, A., H, K., A, G., O, M., A, S., . . . CJ, D. (2023). The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: The TRUCKEE study - 6 month results. Eye (London, England), 37(17), 3574. https://doi.org/10.1038/s41433-023-02553-5

Chicago Style (17th ed.) Citation

AM, Khanani, et al. "The Real-world Efficacy and Safety of Faricimab in Neovascular Age-related Macular Degeneration: The TRUCKEE Study - 6 Month Results." Eye (London, England) 37, no. 17 (2023): 3574. https://doi.org/10.1038/s41433-023-02553-5.

MLA (9th ed.) Citation

AM, Khanani, et al. "The Real-world Efficacy and Safety of Faricimab in Neovascular Age-related Macular Degeneration: The TRUCKEE Study - 6 Month Results." Eye (London, England), vol. 37, no. 17, 2023, p. 3574, https://doi.org/10.1038/s41433-023-02553-5.